Only one of these popular cannabis stocks should be in your portfolio – and it’s not the one on Robinhood’s Top 100 list…

If you’re reading this right now, I don’t have to convince you that cannabis investing is an opportunity that only comes around once in a generation.

You already know that.

But legal cannabis is still such a young industry that it’s not easy separating the winners from the wannabes…

Unless you have the National Institute for Cannabis Investors (NICI) in your corner.

We know the companies to invest in right now that will make you rich; everyone else will be kicking themselves for not buying them sooner as prices skyrocket.

Equally as important – we know the companies to avoid.

That’s why I sat down with Advisory Board member Danny Brody for the popular NICI series Underrated or Overrated? and put two well-known companies in the cannabis investing hot seat: Curaleaf Holdings Inc. (OTC: CURLF) and Hexo Corp. (NYSE: HEXO).

They each have stats that sound impressive on paper. Curaleaf is a leader in the United States in terms of its operational footprint (23 states) and dispensaries (106). By the end of the year, it could also be the largest company by sales.

Once an impending acquisition closes, Hexo will have the number one market share for recreational cannabis sold in Canada, with the top spot in sales in four of Canada‘s largest markets: Alberta, British Columbia, Quebec, and Ontario. It’s also regularly featured on Robinhood‘s Top 100 list of popular stocks.

But there’s a big difference between sounding good on paper and making you a lot of money.

Here’s how we rated each company so that you know where to put your hard-earned cash for the biggest potential returns…

Did you know? You can watch all our Underrated or Overrated? episodes free 24/7 on NICI TV right here.

Are These Popular Yet “Toxic” Stocks Lurking in Your Portfolio?

Like you just saw with HEXO, just because a stock is popular, doesn’t mean it’ll make you money. In fact, some of the most popular stocks on the market right now are ones I wouldn’t recommend you touch with a 10-foot pole. I don’t want you to make the same mistakes as those investors.

That’s why I made sure you have FREE access to my colleague’s complete list of the best and worst stocks to own in 2021. It includes all the popular stocks that you might not realize are “toxic,” but that every investor should consider dropping immediately – plus dozens of winners to boost your portfolio.

It’s all right here.

Take care,

Don Yocham
Executive Director, National Institute for Cannabis Investors


5 responses to “Underrated or Overrated? Popular Cannabis Stocks HEXO and Curaleaf Are Put in the Hot Seat to Find Out If They’re Worth Your Money”

  1. I watched the market April 2020 5.17 a share to 51.70 2021 April or March I have been thinking 🤔 about this and I let myself down again for not buying it

  2. I Own those stocks in those 2 companies you mentioned, I like to see your opinion and what companies you recommend

Leave a Reply

Your email address will not be published. Required fields are marked *